PHARMOS CORP
10-Q, EX-27, 2000-08-11
PHARMACEUTICAL PREPARATIONS
Previous: PHARMOS CORP, 10-Q, 2000-08-11
Next: PNC FINANCIAL SERVICES GROUP INC, 13F-HR, 2000-08-11



<TABLE> <S> <C>


<ARTICLE>                     5

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                              DEC-31-2000
<PERIOD-END>                                   JUN-30-2000
<CASH>                                         18,210,378
<SECURITIES>                                   0
<RECEIVABLES>                                  958,663
<ALLOWANCES>                                   0
<INVENTORY>                                    1,429,393
<CURRENT-ASSETS>                               21,277,608
<PP&E>                                         3,186,992
<DEPRECIATION>                                 1,808,072
<TOTAL-ASSETS>                                 22,889,585
<CURRENT-LIABILITIES>                          3,784,397
<BONDS>                                        0
                          0
                                    0
<COMMON>                                       1,580,135
<OTHER-SE>                                     17,140,080
<TOTAL-LIABILITY-AND-EQUITY>                   22,889,585
<SALES>                                        2,078,417
<TOTAL-REVENUES>                               2,078,417
<CGS>                                          757,691
<TOTAL-COSTS>                                  4,500,273
<OTHER-EXPENSES>                               431,262
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             3,209
<INCOME-PRETAX>                                (2,745,076)
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            (2,745,076)
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (2,745,076)
<EPS-BASIC>                                    (.05)
<EPS-DILUTED>                                  (.05)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission